CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop rapid detection methods for multidrug-resistant and extensively drug-resistant tuberculosis strains. It focuses on creating a colorimetric assay and a molecular tool for quick diagnosis, which will enhance treatment options for affected patients, particularly those with HIV.
Tuberculosis (TB) continues being a leading cause of death due to a single infectious disease agent.
The HIV/AIDS pandemic and the emergence of drug resistance are compounding factors that hinder the control of the disease.
Associated with this problem is the emergence of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, defined as strains resistant to at least isoniazid and rifampicin, the most valuable drugs in the treatment of the disease.
More recently, the appearance of exten…
INSTITUUT VOOR TROPISCHE GENEESKUNDE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Braunschweig
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
